insights_auto
Why is MVIR up 3,22%?
Dive Deeperchevron_right
MVIR:STO
Medivir AB
SEKÂ 1,54
arrow_upward
+3,22%(+0,048) 1D
26 Okt., 17:29:39 GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MVIR...
Open
SEKÂ 1,48
High
SEKÂ 1,55
Low
SEKÂ 1,47
Mkt. cap
959,99Â m
Avg. vol.
1,32Â m
Volume
811,36Â k
52-wk high
SEKÂ 2,88
52-wk low
SEKÂ 0,34
EPS
-SEKÂ 0,37
Shares outstanding
624,18Â m
No. of employees
6
Open
SEKÂ 1,48
High
SEKÂ 1,55
Low
SEKÂ 1,47
Mkt. cap
959,99Â m
Avg. vol.
1,32Â m
Volume
811,36Â k
52-wk high
SEKÂ 2,88
52-wk low
SEKÂ 0,34
EPS
-SEKÂ 0,37
Shares outstanding
624,18Â m
No. of employees
6
News stories
From web sources and news partners
TradingView
·
46 minute gelede
Dow, S&P 500, Nasdaq Futures Climb As Tech Stocks Get A Boost From Anthropic IPO: SOFI, BB, PYPL, CLS In Focus
kaohoon international
·
56 minute gelede
Asia-Pacific Markets Rise as Anthropic’s Nasdaq IPO Plans Fuel Optimism in US Tech Sector
Yahoo Finance
·
7 uur gelede
The 2 S&P 500 Stocks That Could Possibly Hold Up the Whole Index if the AI Trade Collapses
Bloomberg.com
·
3 uur gelede
Asian Stocks to Gain as Anthropic Files for IPO: Markets Wrap
Profile
Medivir is a Swedish biotech company. Medivir focuses its research focus on oncology and particularly on innovative pharmaceuticals that meet substantial unmet medical needs. The pharmaceutical development work is conducted both in-house and through partnerships, usually with global pharmaceutical companies.
Medivir has a leading expertise in the design of protease inhibitors and in the science of nucleotides and nucleosides.
Medivir is listed on the Nasdaq Stockholm Mid Cap List.
In February 2020, Medivir announced that the company has signed a licensing agreement for Xerclear with Chinese company Shijiazhuang Yuanmai Biotechnology Co Ltd. The agreement gives SYB the right to register, manufacture and market the product in China. Wikipedia
About Medivir AB